Here’s a breakdown of the key information from the provided text:
the problem:
* High Cost of Cystic Fibrosis Treatment: The existing drug (made by Vertex) for cystic fibrosis is prohibitively expensive, leading to suffering adn death for those who can’t afford it. Gayle Pledger highlights this,stating,”we’ve watched children suffer and die while a treatment sat on the shelf,priced out of reach.”
* Undiagnosed Cases: Many people worldwide (around 80,000) have undiagnosed cystic fibrosis, particularly in low- and middle-income countries, partly becuase treatment has been inaccessible.
The Solution: Triko (Generic ETI)
* Manufacturer: Bangladeshi company Beximco will manufacture a generic version of the drug, called Triko.
* Availability: Triko will be available starting in spring 2026.
* Pricing:
* Adults: $12,750 per year
* Children: $6,375 per year
* Potential for further reduction: South African doctors believe a reduced dosage protocol could lower the cost to as little as $2,000 per year.
* Cost Comparison: Triko will treat 58 children for the cost of treating one with Vertex’s drug.
How it’s Possible:
* Bangladesh’s Status: Bangladesh is classified as a “least developed country,” which exempts it from certain international intellectual property laws, allowing Beximco to produce the generic drug.
* Importation: Most countries allow individuals to import medications for personal use.
* Collective Action: The breakthrough was achieved through the collaborative efforts of Just Treatment and the Third World Network, who approached Beximco three years ago.
Key People/Organizations:
* Gayle Pledger: A UK parent and full-time campaigner with Just Treatment, whose daughter has cystic fibrosis. She is a driving force behind the effort to make the drug accessible.
* Beximco: the Bangladeshi pharmaceutical company manufacturing Triko.
* Just Treatment: A campaign group advocating for affordable access to cystic fibrosis treatment.
* Third World Network: An association that collaborated with Just Treatment to approach Beximco.
